Literature DB >> 24514895

Does Co-morbidity provide significant improvement on age adjustment when predicting medical outcomes?

G Mnatzaganian1, P Ryan, J E Hiller.   

Abstract

OBJECTIVE: Using three risk-adjustment methods we evaluated whether co-morbidity derived from electronic hospital patient data provided significant improvement on age adjustment when predicting major outcomes following an elective total joint replacement (TJR) due to osteoarthritis.
METHODS: Longitudinal data from 819 elderly men who had had a TJR were integrated with hospital morbidity data (HMD) and mortality records. For each participant, any morbidity or health-related outcome was retrieved from the linked data in the period 1970 through to 2007 and this enabled us to better account for patient co-morbidities. Co-morbidities recorded in the HMD in all admissions preceding the index TJR admission were used to construct three risk-adjustment methods, namely Charlson co-morbidity index (CCI), Elixhauser's adjustment method, and number of co-morbidities. Postoperative outcomes evaluated included length of hospital stay, 90-day readmission, and 1-year and 2-year mortality. These were modelled using Cox proportional hazards regression as a function of age for the baseline models, and as a function of age and each of the risk-adjustment methods. The difference in the statistical performance between the models that included age alone and those that also included the co-morbidity adjustment method was assessed by measuring the difference in the Harrell's C estimates between pairs of models applied to the same patient data using Bootstrap analysis with 1000 replications.
RESULTS: Number of co-morbidities did not provide any significant improvement in model discrimination when added to baseline models observed in all outcomes. CCI significantly improved model discrimination when predicting post-operative mortality but not when length of stay or readmission was modelled. For every one point increase in CCI, postoperative 1- and 2-year mortality increased by 37% and 30%, respectively. Elixhauser's method outperformed the other two providing significant improvement on age adjustment in all outcomes.
CONCLUSION: The predictive performance of co-morbidity derived from electronic hospital data is outcome and risk-adjustment method specific.

Entities:  

Keywords:  Hospital morbidity data; age; co-morbidity adjustment method; length of stay; model discrimination; mortality; readmission

Mesh:

Year:  2014        PMID: 24514895     DOI: 10.3414/ME13-01-0095

Source DB:  PubMed          Journal:  Methods Inf Med        ISSN: 0026-1270            Impact factor:   2.176


  6 in total

1.  Improving Bridging from Informatics Theory to Practice.

Authors:  R Haux; S Koch
Journal:  Appl Clin Inform       Date:  2015-12-23       Impact factor: 2.342

2.  Standard Comorbidity Measures Do Not Predict Patient-reported Outcomes 1 Year After Total Hip Arthroplasty.

Authors:  Meridith E Greene; Ola Rolfson; Max Gordon; Göran Garellick; Szilard Nemes
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

3.  Development and Testing of Compatible Diagnosis Code Lists for the Functional Comorbidity Index: International Classification of Diseases, Ninth Revision, Clinical Modification and International Classification of Diseases, 10th Revision, Clinical Modification.

Authors:  Jeanne M Sears; Sean D Rundell
Journal:  Med Care       Date:  2020-12       Impact factor: 3.178

4.  Comorbidity does not predict long-term mortality after total hip arthroplasty.

Authors:  Erik Bülow; Ola Rolfson; Peter Cnudde; Cecilia Rogmark; Göran Garellick; Szilárd Nemes
Journal:  Acta Orthop       Date:  2017-06-28       Impact factor: 3.717

5.  Risk Factors for Readmission After Knee Arthroplasty Based on Predictive Models: A Systematic Review.

Authors:  Satish M Mahajan; Chantal Nguyen; Justin Bui; Enomwoyi Kunde; Bruce T Abbott; Amey S Mahajan
Journal:  Arthroplast Today       Date:  2020-06-17

6.  Sex differences in in-hospital mortality following a first acute myocardial infarction: symptomatology, delayed presentation, and hospital setting.

Authors:  George Mnatzaganian; George Braitberg; Janet E Hiller; Lisa Kuhn; Rose Chapman
Journal:  BMC Cardiovasc Disord       Date:  2016-05-26       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.